Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding

This paper considers combining a proof of concept (POC) study and a dose finding (DF) study where the POC and the DF share the same primary endpoint. An example based on real study conditions shows that compared to a conventional design the proposed adaptive design tests more active doses, with a sm...

Full description

Bibliographic Details
Main Authors: Jiacheng Yuan, Daniel Radecki, Denise Bugarin, Till Geib, Jihao Zhou, Jeen Liu
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865417301977
_version_ 1818486753185497088
author Jiacheng Yuan
Daniel Radecki
Denise Bugarin
Till Geib
Jihao Zhou
Jeen Liu
author_facet Jiacheng Yuan
Daniel Radecki
Denise Bugarin
Till Geib
Jihao Zhou
Jeen Liu
author_sort Jiacheng Yuan
collection DOAJ
description This paper considers combining a proof of concept (POC) study and a dose finding (DF) study where the POC and the DF share the same primary endpoint. An example based on real study conditions shows that compared to a conventional design the proposed adaptive design tests more active doses, with a smaller sample size and a shorter overall duration leading to a budget saving of 30% in study operations. Keywords: Adaptive design, Dose finding, Proof of concept, Seamless design, Budget saving
first_indexed 2024-12-10T16:27:13Z
format Article
id doaj.art-772867899b184ebfb68560186063a376
institution Directory Open Access Journal
issn 2451-8654
language English
last_indexed 2024-12-10T16:27:13Z
publishDate 2018-09-01
publisher Elsevier
record_format Article
series Contemporary Clinical Trials Communications
spelling doaj.art-772867899b184ebfb68560186063a3762022-12-22T01:41:39ZengElsevierContemporary Clinical Trials Communications2451-86542018-09-01118388Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose findingJiacheng Yuan0Daniel Radecki1Denise Bugarin2Till Geib3Jihao Zhou4Jeen Liu5Corresponding author.; Allergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAAllergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAAllergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAAllergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAAllergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAAllergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USAThis paper considers combining a proof of concept (POC) study and a dose finding (DF) study where the POC and the DF share the same primary endpoint. An example based on real study conditions shows that compared to a conventional design the proposed adaptive design tests more active doses, with a smaller sample size and a shorter overall duration leading to a budget saving of 30% in study operations. Keywords: Adaptive design, Dose finding, Proof of concept, Seamless design, Budget savinghttp://www.sciencedirect.com/science/article/pii/S2451865417301977
spellingShingle Jiacheng Yuan
Daniel Radecki
Denise Bugarin
Till Geib
Jihao Zhou
Jeen Liu
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
Contemporary Clinical Trials Communications
title Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
title_full Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
title_fullStr Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
title_full_unstemmed Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
title_short Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
title_sort seamless phase iia iib adaptive design with the same primary endpoint for proof of concept and dose finding
url http://www.sciencedirect.com/science/article/pii/S2451865417301977
work_keys_str_mv AT jiachengyuan seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding
AT danielradecki seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding
AT denisebugarin seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding
AT tillgeib seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding
AT jihaozhou seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding
AT jeenliu seamlessphaseiiaiibadaptivedesignwiththesameprimaryendpointforproofofconceptanddosefinding